Moldwin Robert MD

Robert Moldwin, MD, FACS is Director of the Pelvic Pain Center at The Arthur Smith Institute for Urology and serves as physician-in-charge of Urologic Infectious/Inflammatory Diseases. He is Professor of Urology at the Hofstra North Shore-LIJ School of Medicine. A world-renowned leader in the field of pelvic pain, Dr. Moldwin has special interests in varied pain syndromes of the bladder and pelvis. His other clinical and research interests range from urinary incontinence to infectious diseases of the urinary tract. Dr. Moldwin is published in peer-reviewed journals including Cancer, The Journal of Urology, The British Journal of Urology International, The British Medical Journal, Contemporary Urology and Urology. Dr. Moldwin is an expert consultant, lecturing to audiences of physicians, patients and members of the media on issues including incontinence, urological health, interstitial cystitis and pelvic disorders. Dr. Moldwin currently serves on multiple medical advisory boards including the Interstitial Cystitis Association, where he serves on the Board of Directors. He is affiliated with numerous medical societies including American Urological Association, International Association for the Study of Pain and The Society for Female Urology and Urodynamics. He is past president of the Society for Infections and Inflammation in Urology and is a committee member who updates the American Urological Association s IC/BPS Guidelines. He is also co-chairperson for Multidisciplinary Approaches to the Study of Chronic Pelvic Pain, a research study sponsored by the National Institutes of Health. After earning his medical degree at the University of Chicago Pritzker School of Medicine, Dr. Moldwin completed his general surgical training and urology residency at the Long Island Jewish Medical Center. He also served as a Valentine Fellow through the New York Academy of Medicine, studying infectious and inflammatory urological diseases in the Department of Urology at Thomas Jefferson Medical College in Philadelphia.